logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Elizabeth Helen Kelley

This inventor holds 9 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignees: Relay Therapeutics, Inc., Merck Sharp + Dohme Corp., D.e. Shaw Research, LLC. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Helen Kelley. Retrieved from https://idiyas.com/inventor/elizabeth-helen-kelley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 100.0

 

Average Co-Inventor Count = 13.7

ph-index = 3

Forward Citations = 27(Granted Patents)


Location History:

  • Lynnfield, MA (US) (2014 - 2016)
  • Cambridge, MA (US) (2015 - 2024)

Company Filing History:

goldMedal5 out of 14 
 
Relay Therapeutics, Inc.
 patents
silverMedal4 out of 2,405 
 
Merck Sharp + Dohme Corp.
 patents
bronzeMedal3 out of 31 
 
D.e. Shaw Research, LLC
 patents
where one patent can have more than one assignee

Years Active: 2014-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents
1. 12331056 - SHP2 phosphatase inhibitors and methods of use thereof (2025-06-17),
2. 12084447 - SHP2 phosphatase inhibitors and methods of use thereof (2024-09-10),
3. 11629145 - SHP2 phosphatase inhibitors and methods of use thereof (2023-04-18),
4. 11591336 - Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors (2023-02-28),
5. 10934302 - SHP2 phosphatase inhibitors and methods of use thereof (2021-03-02),
6. 9469615 - [object Object] (2016-10-18),
7. 9023865 - Compounds that are ERK inhibitors (2015-05-05),
8. 8927559 - [object Object] (2015-01-06),
9. 8871796 - Diaryl ether derivatives as notch sparing gamma secretase inhibitors (2014-10-28),

Title: Elizabeth Helen Kelley: Pioneering Innovator in the World of Inventions

Introduction:

Elizabeth Helen Kelley, a trailblazer in the realm of inventions, has captivated the world with her passion for innovation and unwavering dedication to excellence. Hailing from Cambridge, MA, her groundbreaking work continues to inspire budding inventors to push boundaries and craft solutions that shape our society.

Latest Patents:

1. SHP2 phosphatase inhibitors and methods of use thereof:

- Novel compounds and pharmaceutical compositions for inhibiting SHP2 phosphatase activity and treating associated disorders.

2. Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors:

- Compounds, pharmaceutical compositions, and methods for inhibiting SHP2 phosphatase activity and addressing related disorders.

Career Highlights:

Elizabeth Helen Kelley's illustrious career includes significant contributions at esteemed companies like Merck Sharp & Dohme Corporation and Relay Therapeutics, Inc. Her innovative spirit and commitment to excellence have been key drivers in her successful patent portfolio.

Collaborations:

Throughout her journey, Elizabeth has collaborated with accomplished professionals such as Phieng Siliphaivanh and Joey Lee Methot. These partnerships have fueled creativity and fostered a collaborative environment for groundbreaking inventions.

Conclusion:

In conclusion, Elizabeth Helen Kelley's indelible mark in the world of inventions serves as a beacon of inspiration for generations to come. Her relentless pursuit of innovation and commitment to excellence continue to redefine what is possible in the realm of inventions, leaving an enduring legacy that shapes the future of our world.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…